S‐nitrosylated protein disulfide isomerase contributes to mutant SOD1 aggregates in amyotrophic lateral sclerosis. (1st November 2012)

• Record Type: Journal Article
• Authors: Chen, Xueping; Zhang, Xiaosha; Li, Chen; Guan, Teng; Shang, Huifang; Cui, Liying; Li, Xin‐Min; Kong, Jiming
• Is Part Of: Journal of neurochemistry. Volume 124:Number 1(2013:Jan.)
• Page Start: 45
• Page End: 58
• Publication Date: 2012-11-01
• Subjects: Neurochemistry -- Periodicals; 616.8042
• DOI: 10.1111/jnc.12046
• Languages: English
• ISSNs: 0022-3042

Abstract

<abstract abstract-type="main" id="jnc12046-abs-0001"> <title>Abstract</title> <p>A major hallmark of mutant superoxide dismutase (SOD1)‐linked familial amyotrophic lateral sclerosis is SOD1‐immunopositive inclusions found within motor neurons. The mechanism by which SOD1 becomes aggregated, however, remains unclear. In this study, we aimed to investigate the role of nitrosative stress and S‐nitrosylation of protein disulfide isomerase (PDI) in the formation of SOD1 aggregates. Our data show that with disease progression inducible nitric oxide synthase (iNOS) was up‐regulated, which generated high levels of nitric oxide (NO) and subsequently induced S‐nitrosylation of PDI in the spinal cord of mutant SOD1 transgenic mice. This was further confirmed by <italic>in vitro</italic> observation that treating SH‐SY5Y cells with NO donor S‐nitrosocysteine triggered a dose‐dependent formation of S‐nitrosylated PDI. When mutant SOD1 was over‐expressed in SH‐SY5Y cells, the iNOS expression was up‐regulated, and NO generation was consequently increased. Furthermore, both S‐nitrosylation of PDI and the formation of mutant SOD1 aggregates were detected in the cells expressing mutant SOD1<sup>G93A</sup>. Blocking NO generation with the NOS inhibitor N‐nitro‐<sc>l</sc>‐arginine attenuated the S‐nitrosylation of PDI and inhibited the formation of mutant SOD1 aggregates. We conclude that NO‐mediated S‐nitrosylation of PDI is a contributing factor to the accumulation of mutant SOD1 aggregates in amyotrophic lateral sclerosis.</p> </abstract>